How many anti‑Xa international units are in a 5,000‑unit vial of dalteparin sodium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dalteparin Sodium Anti-Xa Units

A 5,000-unit vial of dalteparin sodium contains 5,000 anti-Xa international units (IU). The units of dalteparin are directly expressed as anti-Xa international units, meaning there is a 1:1 correspondence 1, 2.

Key Clinical Context

Dalteparin is a low-molecular-weight heparin with a mean molecular weight of approximately 5,000 daltons 3. The dosing is standardized based on anti-Xa activity:

  • Prophylactic dosing: 5,000 anti-Xa IU once daily is the standard dose for VTE prophylaxis in hospitalized medical patients, surgical patients, and many outpatients 1
  • Therapeutic dosing: Ranges from 100 IU/kg every 12 hours to 200 IU/kg once daily for treatment of established VTE 1

Important Clinical Considerations

Target anti-Xa levels vary by indication:

  • Prophylactic range: 0.2-0.4 IU/mL
  • Therapeutic range: 0.5-1.0 IU/mL 4, 5

Monitoring is generally not required for standard prophylactic dosing, but anti-Xa monitoring should be considered in specific populations 6:

  • Renal insufficiency (creatinine clearance <60 mL/min)
  • Morbid obesity (BMI >50)
  • Pregnancy
  • Critically ill patients where wide interindividual variation in absorption and clearance occurs 4

When monitoring is performed, samples must be drawn 3-5 hours after subcutaneous injection and after steady state (at least 3 doses) to be clinically meaningful 6. Non-compliance with proper sampling timing is common (48% in one study) and leads to unjustified dose adjustments 6.

Dose adjustments may be needed in high-risk populations. In trauma patients, 51% had subtherapeutic anti-Xa levels with once-daily 5,000 IU dosing, and switching to twice-daily dosing reduced VTE rates 7. Younger age and higher weight predict lower anti-Xa levels 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.